Bat Yam, Israel

Irina Gribun

This inventor holds 1 USPTO granted patent. Top assignee: Chemagis Ltd.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irina Gribun. Retrieved from https://idiyas.com/inventor/irina-gribun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Irina Gribun: Innovator in Pharmaceutical Chemistry

Introduction

Irina Gribun is a notable inventor based in Bat Yam, Israel. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel processes for drug formulation. Her work is characterized by a focus on purity and efficacy in pharmaceutical compounds.

Latest Patents

Irina holds a patent for the "Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride." This invention provides a crystalline donepezil maleate, which serves as an intermediate in the preparation of donepezil hydrochloride. The patent also outlines innovative processes for producing the compound in substantially pure form, as well as a method for creating pharmaceutically pure amorphous donepezil hydrochloride from it. She has 1 patent to her name.

Career Highlights

Irina is currently associated with Chemagis Ltd., where she applies her expertise in pharmaceutical development. Her work at the company has been instrumental in advancing the formulation of effective medications.

Collaborations

Irina collaborates with talented professionals in her field, including Oded Arad and Lior Zelikovitch. Their combined efforts contribute to the innovative projects at Chemagis Ltd.

Conclusion

Irina Gribun's contributions to pharmaceutical chemistry exemplify her dedication to innovation and excellence. Her patent work and collaborations highlight her role as a key figure in the development of effective pharmaceutical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…